These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2970133)

  • 21. Cells mediating allograft rejection.
    Hall BM; Dorsch SE
    Immunol Rev; 1984; 77():31-59. PubMed ID: 6232202
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine mRNA expression during experimental corneal allograft rejection.
    Torres PF; De Vos AF; van der Gaag R; Martins B; Kijlstra A
    Exp Eye Res; 1996 Oct; 63(4):453-61. PubMed ID: 8944552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxp3-expressing sensitized Teff cells prolong survival of corneal allograft in corneal allograft transplantation mouse model.
    Zhao J; Li Z; Wang L; Liu J; Wang D; Chen G; Wang Q; Zhang H
    Transpl Immunol; 2015 Nov; 33(3):192-7. PubMed ID: 26419203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection.
    Lowry RP; Gurley KE; Forbes RD
    Transplantation; 1983 Oct; 36(4):391-401. PubMed ID: 6353707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders.
    Peeler JS; Callanan DG; Luckenbach MW; Niederkorn JY
    J Exp Med; 1988 Nov; 168(5):1749-66. PubMed ID: 2972795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local gene transfer to modulate rat corneal allograft rejection.
    Jessup CF; Brereton HM; Sykes PJ; Thiel MA; Coster DJ; Williams KA
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1675-81. PubMed ID: 15851568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection.
    Larkin DF; Calder VL; Lightman SL
    Clin Exp Immunol; 1997 Feb; 107(2):381-91. PubMed ID: 9030879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of rejection of orthotopic corneal allografts in the rat.
    Callanan D; Peeler J; Niederkorn JY
    Transplantation; 1988 Feb; 45(2):437-43. PubMed ID: 3278439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental corneal allograft rejection.
    Gebhardt BM; Shi W
    Immunol Res; 2002; 25(1):1-26. PubMed ID: 11868932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+ T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4+ T cells.
    Higuchi R; Streilein JW
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):175-82. PubMed ID: 12506072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of MHC class II antigens and immunoglobulin M by the corneal epithelial cells in herpetic keratitis.
    Abu el-Asrar AM; Geboes K; Missotten L; Emarah MH; Desmet V
    Int Ophthalmol; 1990 Jul; 14(4):233-9. PubMed ID: 2142484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of corneal inflammation following the injection of heterologous serum into the rat cornea.
    Verhagen C; Den Heijer R; Broersma L; Breebaart AC; Kijlstra A
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3238-44. PubMed ID: 1836205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depletion of donor-derived Langerhans cells promotes corneal allograft survival.
    He YG; Niederkorn JY
    Cornea; 1996 Jan; 15(1):82-9. PubMed ID: 8907386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.